Literature DB >> 23692567

Human B-1 cells take the stage.

Thomas L Rothstein1, Daniel O Griffin, Nichol E Holodick, Tam D Quach, Hiroaki Kaku.   

Abstract

B-1 cells play critical roles in defending against microbial invasion and in housekeeping removal of cellular debris. B-1 cells secrete natural antibody and manifest functions that influence T cell expansion and differentiation and in these and other ways differ from conventional B-2 cells. B-1 cells were originally studied in mice where they are easily distinguished from B-2 cells, but their identity in the human system remained poorly defined for many years. Recently, functional criteria for human B-1 cells were established on the basis of murine findings, and reverse engineering resulted in identification of the phenotypic profile, CD20(+)CD27(+)CD43(+)CD70(-), for B-1 cells found in both umbilical cord blood and adult peripheral blood. Human B-1 cells may contribute to multiple disease states through production of autoantibody and stimulation/modulation of T cell activity. Human B-1 cells could be a rich source of antibodies useful in treating diseases present in elderly populations where natural antibody protection may have eroded. Manipulation of human B-1 cell numbers and/or activity may be a new avenue for altering T cell function and treating immune dyscrasias.
© 2013 New York Academy of Sciences.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23692567      PMCID: PMC4429725          DOI: 10.1111/nyas.12137

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  190 in total

1.  The unique antigen receptor signaling phenotype of B-1 cells is influenced by locale but induced by antigen.

Authors:  Michael J Chumley; Joseph M Dal Porto; John C Cambier
Journal:  J Immunol       Date:  2002-08-15       Impact factor: 5.422

2.  Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice.

Authors:  J Tian; D Zekzer; L Hanssen; Y Lu; A Olcott; D L Kaufman
Journal:  J Immunol       Date:  2001-07-15       Impact factor: 5.422

3.  Decreased surface IgM receptor-mediated activation of phospholipase C gamma 2 in B-1 lymphocytes.

Authors:  D L Morris; T L Rothstein
Journal:  Int Immunol       Date:  1994-07       Impact factor: 4.823

4.  CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells.

Authors:  G Bikah; J Carey; J R Ciallella; A Tarakhovsky; S Bondada
Journal:  Science       Date:  1996-12-13       Impact factor: 47.728

5.  Lupus-specific antiribonucleoprotein B cell tolerance in nonautoimmune mice is maintained by differentiation to B-1 and governed by B cell receptor signaling thresholds.

Authors:  Y Qian; C Santiago; M Borrero; T F Tedder; S H Clarke
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

6.  Biased immunoglobulin variable region gene expression by Ly-1 B cells due to clonal selection.

Authors:  C A Pennell; T J Mercolino; T A Grdina; L W Arnold; G Haughton; S H Clarke
Journal:  Eur J Immunol       Date:  1989-07       Impact factor: 5.532

7.  Adult BM generates CD5+ B1 cells containing abundant N-region additions.

Authors:  Nichol E Holodick; Karen Repetny; Xuemei Zhong; Thomas L Rothstein
Journal:  Eur J Immunol       Date:  2009-09       Impact factor: 5.532

8.  PD-L2 expression extends beyond dendritic cells/macrophages to B1 cells enriched for V(H)11/V(H)12 and phosphatidylcholine binding.

Authors:  Xuemei Zhong; Joseph R Tumang; Wenda Gao; Chunyan Bai; Thomas L Rothstein
Journal:  Eur J Immunol       Date:  2007-09       Impact factor: 5.532

9.  Accumulation of splenic B1a cells with potent antigen-presenting capability in NZM2410 lupus-prone mice.

Authors:  C Mohan; L Morel; P Yang; E K Wakeland
Journal:  Arthritis Rheum       Date:  1998-09

10.  B-1a B cells that link the innate and adaptive immune responses are lacking in the absence of the spleen.

Authors:  Hedda Wardemann; Thomas Boehm; Neil Dear; Rita Carsetti
Journal:  J Exp Med       Date:  2002-03-18       Impact factor: 14.307

View more
  60 in total

Review 1.  The role of B-1 cells in inflammation.

Authors:  Monowar Aziz; Nichol E Holodick; Thomas L Rothstein; Ping Wang
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

2.  Antibodies to Protein but Not Glycolipid Structures Are Important for Host Defense against Mycoplasma pneumoniae.

Authors:  Patrick M Meyer Sauteur; Adrianus C J M de Bruijn; Catarina Graça; Anne P Tio-Gillen; Silvia C Estevão; Theo Hoogenboezem; Rudi W Hendriks; Christoph Berger; Bart C Jacobs; Annemarie M C van Rossum; Ruth Huizinga; Wendy W J Unger
Journal:  Infect Immun       Date:  2019-01-24       Impact factor: 3.441

Review 3.  Therapeutic Potential of B-1a Cells in COVID-19.

Authors:  Monowar Aziz; Max Brenner; Ping Wang
Journal:  Shock       Date:  2020-11       Impact factor: 3.454

4.  IL-15 temporally reorients IL-10 biased B-1a cells toward IL-12 expression.

Authors:  Amlan Kanti Ghosh; Debolina Sinha; Subhadeep Mukherjee; Ratna Biswas; Tapas Biswas
Journal:  Cell Mol Immunol       Date:  2015-03-09       Impact factor: 11.530

Review 5.  Revisiting the Page & Schroeder model: the good, the bad and the unknowns in the periodontal host response 40 years later.

Authors:  George Hajishengallis; Jonathan M Korostoff
Journal:  Periodontol 2000       Date:  2017-10       Impact factor: 7.589

6.  Developmental expression of B cell molecules in equine lymphoid tissues.

Authors:  J M B Prieto; R L Tallmadge; M J B Felippe
Journal:  Vet Immunol Immunopathol       Date:  2016-12-13       Impact factor: 2.046

7.  Analysis of subsets of B cells, Breg, CD4Treg and CD8Treg cells in adult patients with primary selective IgM deficiency.

Authors:  Ankmalika Gupta Louis; Sudhanshu Agrawal; Sudhir Gupta
Journal:  Am J Clin Exp Immunol       Date:  2016-03-23

8.  Analysis of IgM antibody production and repertoire in a mouse model of Sjögren's syndrome.

Authors:  Jill M Kramer; Nichol E Holodick; Teresa C Vizconde; Indu Raman; Mei Yan; Quan-Zhen Li; Daniel P Gaile; Thomas L Rothstein
Journal:  J Leukoc Biol       Date:  2015-09-17       Impact factor: 4.962

9.  Immune and Inflammatory Determinants Underlying Alzheimer's Disease Pathology.

Authors:  Janet E Baulch; Munjal M Acharya; Sudhanshu Agrawal; Lauren A Apodaca; Clarice Monteiro; Anshu Agrawal
Journal:  J Neuroimmune Pharmacol       Date:  2020-02-24       Impact factor: 4.147

10.  OMIP-068: High-Dimensional Characterization of Global and Antigen-Specific B Cells in Chronic Infection.

Authors:  Katherine Cascino; Mario Roederer; Thomas Liechti
Journal:  Cytometry A       Date:  2020-08-28       Impact factor: 4.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.